Apollomics, Inc. (NASDAQ:APLMW) Short Interest Down 8.8% in April

Apollomics, Inc. (NASDAQ:APLMW) saw a significant decline in short interest in April. As of April 15th, there was short interest totalling 47,900 shares, a decline of 8.8% from the March 31st total of 52,500 shares. Based on an average daily volume of 11,900 shares, the days-to-cover ratio is presently 4.0 days.

Apollomics Trading Up 36.8 %

NASDAQ APLMW opened at $0.03 on Monday. The business’s 50-day moving average price is $0.03 and its 200 day moving average price is $0.03. Apollomics has a twelve month low of $0.01 and a twelve month high of $0.13.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.